Clinical trial Recruiting at 1 site Observational Ages 18 to 90

Comparing ileal insertion depth using a special balloon system versus a standard colonoscope

Official title: Depth of Maximal Insertion During Retrograde Enteroscopy Using Colonoscopy With Through-the-scope Balloon Enteroscopy (NaviAid) Compared With Using the Standard Colonoscope Alone

Run by Texas Tech University Health Sciences Center, El Paso · NCT04646083 · Data updated 2026-11-12

This study is testing whether a special balloon system can help doctors see deeper into the small intestine compared to a regular colonoscope for patients needing enteroscopy.

Quick facts

Study typeObservational
Ages18 Years to 90 Years
SexAll
Enrollment100 (estimated)
SponsorTexas Tech University Health Sciences Center, El Paso
Academic / other
Locations1 site (El Paso, Texas)
StatusRecruiting
StartedJanuary 14, 2021
Main results expectedDecember 31, 2025
Study endsDecember 31, 2025
Registry record updatedJune 18, 2025
Trial IDNCT04646083 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates include adults aged 18-90 who require retrograde enteroscopy for specific gastrointestinal issues.

Probably not a fit

Patients who may not benefit include those with prior colon resection, known strictures, altered anatomy, or inadequate bowel preparation.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to compare the depth of maximal ileal insertion achieved with a through-the-scope balloon enteroscopy system (NaviAid) against a standard adult colonoscope (Olympus CF-190) in patients requiring retrograde enteroscopy. Conducted at the University Medical Center of El Paso, Texas, the study will assess whether the use of the NaviAid system results in greater insertion depth and improved diagnostic yield for small bowel abnormalities. The study will involve a prospective cohort of patients from August 2020 to July 2023, with each patient serving as their own control. The hypothesis is that the NaviAid system will facilitate deeper insertion compared to the standard colonoscope alone.

Why it matters

Potential benefit: If successful, this study could enhance diagnostic capabilities for patients with obscure gastrointestinal bleeding and related conditions.

How similar studies have gone: While the approach of using a through-the-scope balloon system is innovative, similar studies have shown promising results in enhancing diagnostic yield in gastrointestinal procedures.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. Sign Informed Consent Form
2. Patients age between 18-90 years
3. Patients in which retrograde enteroscopy is indicated for any of the following:

abnormal video capsule endoscopy non-diagnostic upper and lower endoscopy obscure gastrointestinal bleeding iron deficiency anemia non-diagnostic upper endoscopy and abnormal CT Hemodynamically stable

Exclusion Criteria:

1. Inability to sign Informed Consent Form
2. Pregnancy and breast feeding
3. Prior colon resection
4. Patients with known strictures
5. Patients with altered anatomy
6. Inadequate bowel preparation.

Where it's running

  • Texas Tech University Health Science Center El Paso
    El Paso, Texas, United States
    Recruiting

Study contacts

  • Principal investigator: Marc J Zuckerman, MD — Texas Tech University Health Sciences Center
  • Study coordinator: Marc J Zuckerman, MD
  • Email: marc.zuckerman@ttuhsc.edu
  • Phone: 9156306163

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.